Barclays to offer ₹200-crore debt facility to Strides Pharma promoter

The proceeds of the debt facility would be used by Karuna Ventures, the promoter company, to repay bank loans and debt raised from other group companies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3GHDlSC
via IFTTT